Related Experiment Video
Updated: Mar 7, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Treatment of Low-Risk Basal Cell Carcinoma
Nicole W J Kelleners-Smeets1, Klara Mosterd1, Patty J Nelemans2
1Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands; GROW, School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Abstract:
With the continuously rising incidence and changing populations of patients with basal cell carcinoma, evidence about the different treatment modalities is mandatory. Randomized clinical trials, such as the surgery versus imiquimod for nodular superficial basal cell carcinoma trial, can provide this evidence. Patients can then be informed about all aspects of alternative treatment options so that conscious, shared decisions can be made.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells

